MOLECULAR AND CELLULAR BIOCHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2025-04-03 ms6000001668743180

偏重的研究方向：分子生物学;肿瘤;分子机制
经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊

12 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2025-06-03 ms3000001225202260 来自上海

5月27投稿
到现在还是Ready for editorial assignment

7 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2025-02-13 ms9000000035738794

偏重的研究方向：心血管
经验分享：20多天了，还没找到编辑

22 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2025-02-05 ms4000001903406605 来自山东省

经验分享：Submission received 25 Nov 2024
Submission is under technical check 25 Nov 2024
Submission passed technical check 27 Nov 2024
Editorial assignment 27 Nov 2024
With Editor 07 Dec 2024
First reviewer(s) invited 09 Dec 2024 
Reviewer(s) accepted 28 Dec 2024 
Reviewer report(s) received 02 Jan 2025
Revision requested 19 Jan 2025
Revision received 30 Jan 2025
Submission passed technical check 31 Jan 2025
First reviewer(s) invited 31 Jan 2025
Reviewer(s) accepted 31 Jan 2025
Reviewer report(s) received 31 Jan 2025
Revision requested 31 Jan 2025
Revision received 03 Feb 2025
Submission passed technical check 04 Feb 2025
Submission accepted 05 Feb 2025

29 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2025-01-06 symzxyy

偏重的研究方向：分子生物学;信号通路;分子机制
经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！#期刊论坛#

35 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2024-11-26 ms4000001903406605 来自山东省

偏重的研究方向：分子;心血管
经验分享：2024.11.25 提交

41 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2024-05-14 ms5000001289597593 来自四川省

请问peer review 是还在编辑手里吗？这个状态已经三周了

114 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2024-10-18 ms7000001381452260 来自广东省

请问editor assigned是分配到编辑了吗？要持续多久啊？

39 5 举报

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2024-04-14 小琪琪cute 来自北京

求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。

207 21 举报

展开21条回复

[GetPortalCommentsPageByObjectIdResponse(id=2258970, encodeId=5de722589e055, content=偏重的研究方向：分子生物学;肿瘤;分子机制 经验分享：这个分配编辑要多久啊，半个月了还没分配到编辑，天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a868263110, createdName=ms6000001668743180, createdTime=Thu Apr 03 15:23:49 CST 2025, time=2025-04-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2267739, encodeId=4aca226e739df, content=5月27投稿 到现在还是Ready for editorial assignment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f9709102559, createdName=ms3000001225202260, createdTime=Tue Jun 03 11:18:02 CST 2025, time=2025-06-03, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2251781, encodeId=a4402251e819a, content=偏重的研究方向：心血管 经验分享：20多天了，还没找到编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf268135566, createdName=ms9000000035738794, createdTime=Thu Feb 13 15:55:50 CST 2025, time=2025-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2250600, encodeId=b4172250600c8, content=经验分享：Submission received 25 Nov 2024 Submission is under technical check 25 Nov 2024 Submission passed technical check 27 Nov 2024 Editorial assignment 27 Nov 2024 With Editor 07 Dec 2024 First reviewer(s) invited 09 Dec 2024  Reviewer(s) accepted 28 Dec 2024  Reviewer report(s) received 02 Jan 2025 Revision requested 19 Jan 2025 Revision received 30 Jan 2025 Submission passed technical check 31 Jan 2025 First reviewer(s) invited 31 Jan 2025 Reviewer(s) accepted 31 Jan 2025 Reviewer report(s) received 31 Jan 2025 Revision requested 31 Jan 2025 Revision received 03 Feb 2025 Submission passed technical check 04 Feb 2025 Submission accepted 05 Feb 2025 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Wed Feb 05 14:28:56 CST 2025, time=2025-02-05, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2246847, encodeId=8b07224684ec7, content=偏重的研究方向：分子生物学;信号通路;分子机制 经验分享：Submission received 10 Aug 2024 Submission is under technical check 10 Aug 2024 Submission passed technical check 11 Aug 2024 Editor assigned 18 Aug 2024 First reviewer(s) invited 25 Aug 2024 Reviewer(s) accepted 16 Dec 2024 Reviewer report(s) received 16 Dec 2024 Revision requested 22 Dec 2024 Revision received 29 Dec 2024 Submission passed technical check 30 Dec 2024 Submission accepted 06 Jan 2025 中间4个月没有消息，写了2封邮件，都回复说在找审稿人，我差点要撤稿了，最后刚刚要放弃时，有一个专家审稿了，提了一些意见，14天修改期，有些是硬伤，不过审稿人说可以讨论一下论文的局限性，于是谦虚谨慎的加了一段论文的不足，今天早上accepted，等一等还是值得的！<a href='/topic/show?id=8f275032126' target=_blank style='color:#2F92EE;'>#期刊论坛#</a> , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50321, encryptionId=8f275032126, topicName=期刊论坛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5a3b1405260, createdName=symzxyy, createdTime=Mon Jan 06 16:29:12 CST 2025, time=2025-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2239199, encodeId=db8322391995f, content=偏重的研究方向：分子;心血管 经验分享：2024.11.25 提交, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9ab49420571, createdName=ms4000001903406605, createdTime=Tue Nov 26 08:59:15 CST 2024, time=2024-11-26, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2204713, encodeId=53582204e13d5, content=请问peer review 是还在编辑手里吗？这个状态已经三周了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6728478382, createdName=ms5000001289597593, createdTime=Tue May 14 20:49:25 CST 2024, time=2024-05-14, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2231623, encodeId=578322316233e, content=请问editor assigned是分配到编辑了吗？要持续多久啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da495455462, createdName=ms7000001381452260, createdTime=Fri Oct 18 21:44:21 CST 2024, time=2024-10-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2198455, encodeId=b71721984553d, content=求问大家peer review要持续多长时间啊？4.2提交，4.3通过技术审查，当天系统上自动变成Submission under peer review（这到底算不算送外审啊），然后就一直没动静了，官网说的first decision 是8天。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=21, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fad45491744, createdName=小琪琪cute, createdTime=Sun Apr 14 14:58:52 CST 2024, time=2024-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2180307, encodeId=84a8218030e30, content=偏重的研究方向：肿瘤 经验分享：这杂志接收后多久收到proof , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b771924899, createdName=zhouhl1089, createdTime=Tue Jan 09 19:02:23 CST 2024, time=2024-01-09, status=1, ipAttribution=)]

2024-01-09 zhouhl1089

偏重的研究方向：肿瘤
经验分享：这杂志接收后多久收到proof

114 8 举报

展开8条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务